Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)
China · Delayed Price · Currency is CNY 11.53
-0.25 (-2.12%)
Oct 12, 2026, 3:04 PM CST
SHE:301060 Market Cap
SHE:301060 has a market cap or net worth of 4.59 billion as of October 9, 2026. It is the 12,560th most valuable company in the world and the 3,215th biggest in China. Its market cap has increased by 24.11% in one year.
Market Cap
4.59B
Enterprise Value
4.03B
Revenue
1.28B
Global Rank
Country Rank
#3,215 China
PE Ratio
89.62
ChartMarket Cap Chart
Since September 13, 2021, SHE:301060's market cap has decreased from 7.32B to 4.59B, a decrease of -37.21%. That is a compound annual growth rate of -8.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 4.59B | 24.65% |
| Dec 31, 2025 | 3.69B | 1.45% |
| Dec 31, 2024 | 3.63B | -31.73% |
| Dec 29, 2023 | 5.32B | -32.23% |
| Dec 30, 2022 | 7.85B | -43.54% |
| Dec 31, 2021 | 13.91B | 90.09% |
| Sep 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 7.75B |
| Beijing Strong Biotechnologies,Inc. | 7.10B |
| Shanghai Runda Medical Technology | 6.03B |
| Maccura Biotechnology Co.Ltd | 5.79B |
| Cowealth Medical China | 5.48B |
| Berry Genomics Co.,Ltd | 3.99B |
| Medicalsystem Biotechnology | 3.96B |
| Guangdong Hybribio Biotech | 3.94B |